Enalaprilat
| CAS No. | 76420-72-9 |
|---|---|
| MDL No. | MFCD00865786 |
| MF | C18H24N2O5 |
| MW | 348.40 |
| InChI Key | LZFZMUMEGBBDTC-QEJZJMRPSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Enalaprilat (anhydrous) is the carboxylic acid form of enalapril, obtained by hydrolysis of the ethyl ester group. It is an ACE inhibitor used in the treatment of hypertension and heart failure, as well as for reducing proteinuria and renal disease in nephropathies, and for preventing stroke, myocardial infarction, and cardiac death in high-risk patients. Unlike enalapril, enalaprilat is not orally absorbed and is administered intravenously, typically as the dihydrate. It functions as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor and an antihypertensive agent. It is a dicarboxylic acid and a dipeptide.
| CAS No. | 76420-72-9 |
|---|---|
| Product Name | Enalaprilat |
Biological Targets
ACE
Associated Conditions
dilated cardiomyopathy·severe cutaneous adverse reaction·hypertension
* The information provided here is compiled from public sources and is for reference only.
